Advertisement

Comprehensive assessment of treatment related problems in hospitalized medicine patients in Jordan

  • Salah M. AbuRuzEmail author
  • Nailya R. Bulatova
  • Al-Moatasem M. Yousef
  • Mutasim A. Al-Ghazawi
  • Izzat A. Alawwa
  • Akram Al-Saleh
Research Article

Abstract

Objectives The aim of this study was to identify the prevalence and characteristics of treatment related problems (TRPs) in hospitalized internal medicine patients in Jordan as well as to identify diseases and drugs associated with each specific TRP. We have also aimed at investigating physicians’ acceptance of recommendations made by clinical pharmacist and to identify the outcomes of pharmacist interventions. Setting Internal medicine department of a general hospital in Jordan. Methods We have utilized a systematic, prospective, bedside, comprehensive clinical assessment approach that allowed us to effectively identify, communicate and follow up TRPs. Main outcome measures: prevalence and nature of identified TRPs, clinical significance of TRPs, associated diseases and drugs and clinical outcomes of clinical pharmacist interventions. Results 402 patients were included in the study. The average number of the identified TRPs was 9.35. Fifty-three percent of identified TRPs were classified as major and 28% were classified as moderate. Ninety-one percent of the recommendations were accepted by physicians. Efficacy related problems were the most common TRP category followed by safety related problems and indication related problems. Sixty-four percent of the TRPs were resolved or prevented through the clinical pharmacist intervention. Conclusions We have found that prevalence of TRPs is substantially high among patients hospitalized at the internal medicine department. TRPs related to Dosage regimens, untreated conditions, patient monitoring, drug interactions, and drug choices were the most common. Most of TRPs identified by pharmacists were clinically significant. Pharmacists’ interventions contributed substantially to the resolving of many of the identified TRPs. Patients suffering from higher number of medical conditions and receiving higher number of medications should be given the priority for clinical pharmacy service in hospitalized internal medicine patients.

Keywords

Clinical pharmacy Drug related problems Internal medicine Jordan Pharmaceutical care Treatment related problems 

Notes

Acknowledgment

The authors wish to thank all patients, pharmacists and physicians who contributed to the success of this work.

Funding

The authors wish to acknowledge the Deanship of Academic Research at the University of Jordan for funding this research which was part of the “Pharmaceutical Care Project in Jordan”.

Conflicts of interest

The authors declare that they have no conflicts of interest to disclose.

References

  1. 1.
    Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash). 2001;41(2):192–9.Google Scholar
  2. 2.
    Institute of Medicine. To err is human: building a safer health system. Washington, DC: National Academy Press; 2000. ISBN: 0-309-06837-1.Google Scholar
  3. 3.
    Thomas EJ, Studdert DM, Burstin HR, et al. Incidence and types of adverse events and negligent care in Utah and Colorado. Med Care. 2000;38(3):261–71.PubMedCrossRefGoogle Scholar
  4. 4.
    Thomas EJ, Studdert DM, Newhouse JP, et al. Costs of medical injuries in Utah and Colorado. Inquiry. 1999;36(3):255–64.PubMedGoogle Scholar
  5. 5.
    Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med. 1991;324(6):370–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med. 1991;324(6):377–84.PubMedCrossRefGoogle Scholar
  7. 7.
    Lagnaoui R, Moore N, Fach J, et al. Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol. 2000;56(2):181–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Winterstein AG, Sauer BC, Hepler CD, et al. Preventable drug-related hospital admissions. Ann Pharmacother. 2002;36(7–8):1238–48.PubMedCrossRefGoogle Scholar
  9. 9.
    Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200–5.PubMedCrossRefGoogle Scholar
  10. 10.
    Bond CA, Raehl CL, Franke T. Clinical pharmacy services and hospital mortality rates. Pharmacotherapy. 1999;19(5):556–64.PubMedCrossRefGoogle Scholar
  11. 11.
    Westerlund T, Marklund B. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems. J Clin Pharm Ther. 2009;34(3):319–27.PubMedCrossRefGoogle Scholar
  12. 12.
    Rao D, Gilbert A, Strand LM, et al. Drug therapy problems found in ambulatory patient populations in Minnesota and South Australia. Pharm World Sci. 2007;29(6):647–54.PubMedCrossRefGoogle Scholar
  13. 13.
    Lewis NJ, Bugdalski-Stutrud C, Abate MA, et al. The medication assessment program: comprehensive medication assessments for persons taking multiple medications for chronic diseases. J Am Pharm Assoc. 2008;48(2):171–80.CrossRefGoogle Scholar
  14. 14.
    Blix HS, Viktil KK, Reikvam A, et al. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol. 2004;60(9):651–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Viktil KK, Blix HS, Reikvam A, et al. Comparison of drug-related problems in different patient groups. Ann Pharmacother. 2004;38(6):942–8.PubMedCrossRefGoogle Scholar
  16. 16.
    De Rijdt T, Willems L, Simoens S. Economic effects of clinical pharmacy interventions: a literature review. Am J Health Syst Pharm. 2008;65(12):1161–72.PubMedCrossRefGoogle Scholar
  17. 17.
    Stafford AC, Tenni PC, Peterson GM, et al. Drug-related problems identified in medication reviews by Australian pharmacists. Pharm World Sci. 2009;31(2):216–23.PubMedCrossRefGoogle Scholar
  18. 18.
    Vessal G. Detection of prescription errors by a unit-based clinical pharmacist in a nephrology ward. Pharm World Sci. 2010;32:59–65.PubMedCrossRefGoogle Scholar
  19. 19.
    Welch EK, Delate T, Chester EA, et al. Assessment of the impact of medication therapy management delivered to home-based Medicare beneficiaries. Ann Pharmacother. 2009;43(4):603–10.PubMedCrossRefGoogle Scholar
  20. 20.
    Castelino RL, Bajorek BV, Chen TF. Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services. Ann Pharmacother. 2009;43(6):1096–106.PubMedCrossRefGoogle Scholar
  21. 21.
    Chap L. Study designs. In: Chap L, editor. Introductory biostatistics. 1st ed. Hoboken, NJ: Wiley; 2003. p. 445. ISBN: 978-0471418160.Google Scholar
  22. 22.
    AbuRuz SM, Bulatova NR, Yousef AM. Validation of a comprehensive classification tool for treatment-related problems. Pharm World Sci. 2006;28(4):222–32.PubMedCrossRefGoogle Scholar
  23. 23.
    AbuRuz SM, Bulatova NR, Yousef AM. Pharmaceutical care manual. Jordan National library; 2007. Copyright number 2007/12/3856.Google Scholar
  24. 24.
    AbuRuz SM. The case for evidence based pharmaceutical care. Research in Social and Administrative Pharmacy (in press). doi:  10.1016/j.sapharm.2009.06.001.
  25. 25.
    Cipolle RJ, Strand L, Morley P. Pharmaceutical care practice: the clinician’s guide. 2nd ed. New York: McGraw-Hill; 2004. ISBN: 978-0071362597.Google Scholar
  26. 26.
    Lacy CF, Armstrong LL. Goldman MP, Lance LL. Lexi-comp’s drug information handbook. 14th ed. Hudson, Oh: Lexi-Comp, Inc.; 2006. ISBN: 978-1591951063.Google Scholar
  27. 27.
    The I-Facts. Facts and comparisons drug interactions facts. St. Louis, MO: Wolters Kluwer Health; 2006. ISBN: 978-0932686480.Google Scholar
  28. 28.
    Dodd C. Assessing pharmacy intervention at Salisbury Health Care NHS trust. Hosp Pharm. 2006;10:451–6.Google Scholar
  29. 29.
    Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.PubMedCrossRefGoogle Scholar
  30. 30.
    Szumita PM. The hospital pharmacist: an integral part of the hyperglycaemic management team. J Clin Pharm Ther. 2009;34:613–21.PubMedCrossRefGoogle Scholar
  31. 31.
    Petrie JL, Segal AR. Clinical pharmacy services provided to asthma patients in a school-based clinic. Am J Health Syst Pharm. 2010; 67(3):185, 188-9.Google Scholar
  32. 32.
    Bedouch P, Allenet B, Grass A. Drug-related problems in medical wards with a computerized physician order entry system. J Clin Pharm Ther. 2009;34(2):187–95.PubMedCrossRefGoogle Scholar
  33. 33.
    Koh Y, Kutty FB, Li SC. Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Manag. 2005;1(1):39–48.PubMedCrossRefGoogle Scholar
  34. 34.
    Dashti-Khavidaki S, Khalili H, Hamishekar H, et al. Clinical pharmacy services in an Iranian teaching hospital: a descriptive study. Pharm World Sci. 2009;31(6):696–700.PubMedCrossRefGoogle Scholar
  35. 35.
    Pastakia SD, Schellhase EM, Jakait B. Collaborative partnership for clinical pharmacy services in Kenya. Am J Health Syst Pharm. 2009;66(15):1386–90.PubMedCrossRefGoogle Scholar
  36. 36.
    de Lyra DP, Kheir N, Abriata JP, et al. Impact of pharmaceutical care interventions in the identification and resolution of drug-related problems and on quality of life in a group of elderly outpatients in Ribeirao Preto (SP), Brazil. Ther Clin Risk Manag. 2007;3(6):989–98.PubMedGoogle Scholar
  37. 37.
    Sadik A, Yousif M, McElnay JC. Pharmaceutical care of patients with heart failure. Br J Clin Pharmacol. 2005;60(2):183–93.PubMedCrossRefGoogle Scholar
  38. 38.
    Al Mazroui NR, Kamal MM, Ghabash NM, Yacout TA, Kole PL, McElnay JC. Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus. Br J Clin Pharmacol. 2009;67(5):547–57.PubMedCrossRefGoogle Scholar
  39. 39.
    Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA. 1997;277(4):312–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Lipton HL, Bero LA, Bird JA, et al. The impact of clinical pharmacists’ consultations on physicians’ geriatric drug prescribing. A randomized controlled trial. Med Care. 1992;30(7):646–58.PubMedCrossRefGoogle Scholar
  41. 41.
    Alderman CP, Farmer C. A brief analysis of clinical pharmacy interventions undertaken in an Australian teaching hospital. J Qual Clin Pract. 2001;21(4):99–103.PubMedCrossRefGoogle Scholar
  42. 42.
    Barber ND, Batty R, Ridout DA. Predicting the rate of physician-accepted interventions by hospital pharmacists in the United Kingdom. Am J Health Syst Pharm. 1997;54(4):397–405.PubMedGoogle Scholar
  43. 43.
    Hanlon JT, Fillenbaum GG, Schmader KE, et al. Inappropriate drug use among community-dwelling elderly. Pharmacotherapy. 2000;20(5):575–82.PubMedCrossRefGoogle Scholar
  44. 44.
    Flaherty JH, Perry HM, Lynchard GS, et al. Polypharmacy and hospitalization among older home care patients. J Gerontol A Biol Sci Med Sci. 2000;55(10):M554–9.PubMedGoogle Scholar
  45. 45.
    Gilbert AL, Roughead EE, Beilby J, et al. Collaborative medication management services: improving patient care. Med J Aust. 2002;177(4):189–92.PubMedGoogle Scholar
  46. 46.
    Gurwitz JH, Rochon P. Improving the quality of medication use in elderly patients: a not-so-simple prescription. Arch Intern Med. 2002;162(15):1670–2.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  • Salah M. AbuRuz
    • 1
    • 2
    Email author
  • Nailya R. Bulatova
    • 1
  • Al-Moatasem M. Yousef
    • 1
  • Mutasim A. Al-Ghazawi
    • 1
  • Izzat A. Alawwa
    • 3
  • Akram Al-Saleh
    • 3
  1. 1.Department of Clinical Pharmacy, Faculty of PharmacyUniversity of JordanAmmanJordan
  2. 2.Department of Pharmaceutical CareJordan University HospitalAmmanJordan
  3. 3.Department of Internal Medicine, Faculty of MedicineUniversity of Jordan and Jordan University HospitalAmmanJordan

Personalised recommendations